Conduit Pharmaceuticals Inc
CDTBuild a strategy around CDT
Conduit Pharmaceuticals Inc AI Insights
Informational only. Not investment advice.Snapshot
- Zero revenue TTM with -16.1M FCF burn implies ~3 quarters cash runway at 3.8M current cash position[Free Cash Flow TTM]
- R&D of 4.4M TTM is just 10% of industry median (45M) - minimal pipeline investment for a pharma company[Research and Development TTM]
- ROE of -166% and ROIC of -116% TTM reflect pre-revenue biotech destroying capital while seeking clinical validation[Return on Equity]
Watch Triggers
- Cash and Equivalents: Falls below 2M or rises above 10M — Below 2M = crisis mode; above 10M = successful raise (watch dilution terms)
- Research and Development TTM: Increases >50% QoQ — Would signal pipeline acceleration and potential catalyst ahead
- Total Revenue TTM: Any revenue recognition >0 — First revenue would transform thesis from speculative to operational
Bull Case
Low debt/equity of 0.44 and minimal long-term debt (8K) means balance sheet is clean for potential acquirer or partnership
Operating expenses of 18.7M TTM are lean vs industry median 101M - efficient burn if pipeline has value
Bear Case
Cash runway under 3 quarters with zero revenue forces near-term dilution or distressed deal at any price
R&D spend at 4.4M (10% of peers) suggests limited pipeline advancement capability without major capital raise
Bull vs Bear Balance
AI-generated sentiment analysis based on fundamental metrics and market conditions.
Leverage CDT's top insights and create a custom strategy based on them in seconds. Our AI editor does it all — in one click.
Forward Thesis
CDT faces imminent dilution or partnership deal within 12 months to fund operations
- 3.8M cash vs 16M annual burn = <3 quarters runway
- 6M equity issuance in recent period shows dilution pattern
- Zero revenue requires external capital for survival
Valuation Context
Caveats
Public Strategies Rankings
See how Conduit Pharmaceuticals Inc ranks across different investment strategies.
Leverage CDT's top insights and create a custom strategy in seconds. Our AI editor does it all — in one click.
CDT Fundamentals
| Metric | Value | YoY Growth | Industry Percentile |
|---|---|---|---|
$2.76M | — | ||
$795,284 | — | ||
0.00 | — | ||
$0 | — | ||
$-179.34 | — | ||
0% | 0.0% | — | |
0% | 0.0% | — | |
$-16.13M | — | ||
0% | — | ||
Beta 5Y (Monthly) | unknown | — |
CDT Dividend History
CDT Stock Splits
CDT SEC Filings
| Filing Date | Report Date | Report Type | Filing Link |
|---|---|---|---|
11/13/25 | 09/30/25 | 10-Q | |
08/14/25 | 06/30/25 | 10-Q | |
08/14/25 | 03/31/25 | 10-Q/A | |
05/15/25 | 03/31/25 | 10-Q | |
03/28/25 | 12/31/24 | 10-K | |
11/14/24 | 09/30/24 | 10-Q | |
08/12/24 | 06/30/24 | 10-Q | |
05/14/24 | 03/31/24 | 10-Q | |
08/14/25 | 03/31/24 | 10-Q/A | |
04/16/24 | 12/31/23 | 10-K | |
11/20/23 | 09/30/23 | 10-Q | |
11/14/24 | 06/30/23 | 10-Q/A | |
07/28/23 | 03/31/23 | S-4/A | |
07/28/23 | 12/31/22 | S-4/A | |
11/21/23 | 09/30/22 | 10-Q/A | |
07/28/23 | 03/31/22 | S-4/A |